# Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker

> **NCT00534300** · PHASE1,PHASE2 · COMPLETED · sponsor: **Aalborg University Hospital** · enrollment: 8 (actual)

## Conditions studied

- Ventricular Tachycardia
- Sudden Cardiac Death

## Interventions

- **DRUG:** Omegaven
- **DRUG:** Isotonic saline

## Key facts

- **NCT ID:** NCT00534300
- **Lead sponsor:** Aalborg University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534300, "Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00534300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*